PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.47%
R&D change of 22.47% versus flat Healthcare spending. Walter Schloss would verify adequacy.
-1.59%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.64%
Operating expenses growth exceeding 1.5x Healthcare median of 9.47%. Jim Chanos would check for waste.
14.64%
Total costs growth exceeding 1.5x Healthcare median of 9.61%. Jim Chanos would check for waste.
No Data
No Data available this quarter, please select a different quarter.
8.11%
D&A growth exceeding 1.5x Healthcare median of 1.07%. Jim Chanos would check for overinvestment.
-14.78%
EBITDA decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-14.64%
Operating income decline while Healthcare median is -1.45%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-24.66%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-15.16%
Pre-tax income decline while Healthcare median is -0.55%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
14.88%
Tax expense change of 14.88% versus flat Healthcare. Walter Schloss would verify strategy.
-15.16%
Net income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
2.78%
EPS change of 2.78% versus flat Healthcare. Walter Schloss would verify quality.
2.78%
Diluted EPS change of 2.78% versus flat Healthcare. Walter Schloss would verify quality.
19.07%
Share count change of 19.07% versus stable Healthcare. Walter Schloss would verify approach.
19.07%
Diluted share change of 19.07% versus stable Healthcare. Walter Schloss would verify approach.